Neurizon beats schedule for key ALS trial milestone
Neurizon Therapeutics (ASX:NUZ) announced that its HEALEY ALS Platform Trial has surpassed the critical 50% dosing milestone.
Every story in this category, newest first.
Neurizon Therapeutics (ASX:NUZ) announced that its HEALEY ALS Platform Trial has surpassed the critical 50% dosing milestone.
Qualitas (ASX:QAL) expanded into Europe by launching a regional private credit platform and acquiring UK-based Starz Real Estate.
On this week's "The Debrief with Mario Parker," Mario breaks down how the relationship between President Donald Trump and Elon Musk has evolved. Earlier this month Trump said Musk is "a friend of mine again." Mario also talks about how some members of the Trump administration stand to gain financially from the SpaceX IPO. He reports on "Balance of Power."
Quantum Graphite (ASX:QGL) has secured a binding ore supply agreement with Sunlands Pure Group.
Monash IVF Group (ASX:MVF) revised its financial outlook for 2026, forecasting an underlying net profit after tax of between $17 million and $18 million.
Australian security software developer icetana (ASX:ICE) signed a pivotal distribution agreement with SoftBank Robotics America.
Pursuit Minerals (ASX:PUR) announced an expansion of its flagship Rio Grande Sur Lithium Project in Salta Province, Argentina.
BHP (ASX:BHP) faces major disruptions as AMWU and ETU members vote for protected strike action at Port Hedland over an ongoing pay dispute.
Singaporean energy giant Sembcorp has finalised its landmark $6.5 billion takeover of Alinta Energy.
ANZ Bank New Zealand has announced that its CEO and ANZ Group (ASX:ANZ) executive, Antonia Watson, will retire.
Beetaloo Energy (ASX:BTL) flagged a mid-June commencement for its critical Carpentaria-5H extended production test.
Australia's economic engine is stalling as labour productivity slipped by 0.6% in the March quarter.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy